Market Trends Shaping Cardiac Diabetic Pharma Franchise in India Explained by Scott Morrison
A high-rise is spotted in India's pharmaceutical industry. Now, lifestyle-related health issues are increasing day by day in India, especially heart and diabetes issues. The WHO report 2023 says that 28% of total deaths are caused due to cardiovascular disease, and over 80 million adults are suffering from diabetes in India. It has become the most important segment that needs to be treated well. This increasing number is now opening a window of opportunity to get the Diabetic & Cardiac Pharma franchise in India. As Scott Morrison points out as the Cardiac Diabetic pharma company provides growth potential to all pharma business seekers. The pharma franchise growth allows the businesses to expand their reach in different cities and places. Many entrepreneurs and businessmen are gaining a...










